Gene expression profiling of prostatectomy specimens also showed that higher PD-L2 expression was prognostic, associated with worse biochemical recurrence, metastatic spread, and prostate cancer specific survival [16]. This evidence concerns the gene PDCD1LG2 and prostate cancer.